Roberto Nitsch

Roberto Nitsch

Company: AstraZeneca

Job title: Associate Director of Clinical Pharmacology & Safety Sciences for CRISPR Medicines

Seminars:

Live Presenter Q&A 12:50 pm

Read more

day: Day One

Panel Discussion: Discuss the Safety of Different Viral & Non-Viral Vectors 1:20 pm

• Understanding the potential biosafety risks of the use of different viral vectors in gene therapy • Discussing topics such as translational mutagenesis leading to carcinogenesis, as well as how disease can be caused by transgene expression • Compare and contrast the viral and non-viral approaches to with regards to safety and immunogenicity of gene…Read more

day: Day One

Safety considerations to deliver better CRISPR medicines 12:30 pm

• Safety aspects of CRISPR applications • Therapeutic uses and consequences of CRISPR • Efficient and safe CRISPR usageRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.